Lupin FY2026 Net Profit Rises 62% to ₹53,555 Mn

Lupin reported FY2026 consolidated PAT of ₹53,555 Mn, a 62.0% YoY increase, with sales growing 23.9% to ₹274,875 Mn.
EBITDA margin expanded significantly by 890 bps to 33.6% for the full year, driven by strong performance in the U.S. and India markets.
The Board recommended a dividend of 900% based on the company's long-term outlook and strong financial performance.
Q4 FY2026 PAT surged 87.7% YoY to ₹14,687 Mn, with U.S. formulations sales up 56.9% and EBITDA margin at 35.5%.